Posttraumatic stress disorder: A missed link between psychiatric and cardiovascular morbidity?

CNS Spectrums

Volumn 11, Issue 2, 2006, Pages 129-136

  Cotter, Gad ^a,d   Milo Cotter, Olga ^a   Rubinstein, David ^b,c   Shemesh, Eyal ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Elmhurst Medical Center   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; COGNITIVE THERAPY; COMORBIDITY; CONTINUING EDUCATION; DISEASE EXACERBATION; HEART FAILURE; HEART INFARCTION; HUMAN; MENTAL DISEASE; PATIENT COMPLIANCE; PATIENT REFERRAL; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; SCREENING TEST; SUICIDAL BEHAVIOR; SYMPTOMATOLOGY;

EID: 33644554798     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S109285290001066X     Document Type: Review

References (44)

1. Barth JP, Schumacher MMA, Herrmann-Lingen CMD. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66:802-813.
2. van Melle JPMD, de Jonge PP, Spijkerman TAMD, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66:814-822.
3. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289:3106-3116.
4. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701-709.
5. Dobson KS. A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol. 1989;57:414-419.
6. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. text rev. Washington, DC: American Psychiatric Association; 2000.
7. Shemesh E, Stuber ML. Posttraumatic stress responses in patients with life-threatening illnesses. CNS Spectr. 2006;2:xx-xx.
8. Billings RF, Kearns PM, Levene DL. The influence of psychological factors on chest pain associated with myocardial infarction. Acta Med Scand Suppl. 1981;644:46-48.
9. Spindler H, Pedersen SS. Posttraumatic stress disorder in the wake of heart disease: prevalence, risk factors, and future research directions. Psychosom Med. 2005;67:715-723.
10. Kutz I, Shabtai H, Solomon Z, Neumann M, David D. Post-traumatic stress disorder in myocardial infarction patients: prevalence study. Isr J Psychiatry Relat Sci. 1994;31:48-56.
11. Ginzburg K, Solomon Z, Bleich A. Repressive coping style, acute stress disorder, and posttraumatic stress disorder after myocardial infarction. Psychosom Med. 2002;64:748-757.
12. Pedersen SS, Middel B, Larsen ML. Posttraumatic stress disorder in first-time myocardial infarction patients. Heart Lung. 2003;32:300-307.
13. Shemesh E, Rudnick A, Kaluski E, et al. A prospective study of posttraumatic stress symptoms and nonadherence in survivors of a myocardial infarction (MI). Gen Hosp Psychiatry. 2001;23:215-222.
14. Shemesh E, Yehuda R, Milo O, et al. Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction. Psychosom Med. 2004;66:521-526.
15. Shemesh E, Michovitz M, Yehuda R, et al. Symptoms of posttraumatic stress disorder in patients who had a myocardial infarction. Psychosomatics. In press.
16. Cotter G., Shemesh E, Zehavi M, Dinur I, Rudnick A, Milo O, Vered Z, Krakover R, Kaluski E, Kornberg A. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? Am Heart J. 2004;147:293-300.
17. Dew MA, Kormos RL, Roth LH, Murali S, DiMartini A, Griffith BP. Early posttransplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant. 1999;18:549-562.
18. Shalev AY, Sahar T, Freedman S, et al. A prospective study of heart rate response following trauma and the subsequent development of posttraumatic stress disorder. Arch Gen Psychiatry. 1998;55:553-559.
19. Nishith P, Duntley SP, Domitrovich PP, Uhles ML, Cook BJ, Stein PK. Effect of cognitive behavioral therapy on heart rate variability during REM sleep in female rape victims with PTSD. J Trauma Stress. 2003;16:247-250.
20. Yehuda R. Current status of cortisol findings in post-traumatic stress disorder. Psychiatr Clin North Am. 2002;25:341-358.
21. Yehuda R. Post-traumatic stress disorder. N Engl J Med. 2002;346:108-114.
22. Yehuda R. Biology of posttraumatic stress disorder. J Clin Psychiatry. 2001;62(suppl 17):41-46.
23. Yehuda R, Halligan SL, Bierer LM. Relationship of parental trauma exposure and PTSD to PTSD, depressive and anxiety disorders in offspring. J Psychiatr Res. 2001;35:261-270.
24. Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ. Cortisol regulation in posttraumatic stress disorder-and major depression: a chronobiological analysis. Biol Psychiatry. 1996;40:79-88.
25. Hapke U, Schumann A, Rumpf HJ, John U, Konerding U, Meyer C. Association of smoking and nicotine dependence with trauma and posttraumatic stress disorder in a general population sample. J Nerv Ment Dis. 2005;193:843-846.
26. Breslau N, Davis GC, Schultz LR. Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma. Arch Gen Psychiatry. 2003;60:289-294.
27. McDermott MM, Schmitt B, Wallner E. IImpact of medication nonadherence on coronary heart disease outcomes. A critical review. Arch Intern Med. 1997;157:1921-1929.
28. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982;247:1707-1714.
29. Gallagher EJ, Viscoli CM, Horwitz RI. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA 1993;270:742-744.
30. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med. 1980;303:1038-1041.
31. Foa EB Psychosocial treatment of posttraumatic stress disorder. J Clin Psychiatry. 2000;61(suppl 5):43-48.
32. Friedman MJ, Donnelly CL, Mellman TA. Pharmacotherapy for PTSD. Psychiatr Ann. 2003;33:57-62.
33. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000;283:1837-1844.
34. Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001;58:485-492.
35. Marshall RD, Beebe KL, Dldham M, Zaninelli R. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158:1982-1988.
36. Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62:860-868.
37. Wessely S, Deahl M. Psychological debriefing is a waste of time. Br J Psychiatry. 2003;183:12-14.
38. Rose S, Bisson J, Wessely S. A systematic review of single-session psychological interventions ('debriefing') following trauma. Psychother Psychosom. 2003;72:176-184.
39. McFarlane AC. Debriefing: care and sympathy are not enough. Med J Aust. 2003;178:533-534.
40. van Emmerik AA, Kamphuis JH, Hulsbosch AM, Emmelkamp PM. Single session debriefing after psychological trauma: a meta-analysis. Lancet. 2002;360:766-771.
41. Gist R, Devilly GJ. Post-trauma debriefing: the road too frequently travelled. Lancet. 2002;360:741-742.
42. Yehuda R, ed. Psychological Trauma. Washington, DC: American Psychiatric Press; 1998.
43. Yehuda R, ed. Treating Trauma Survivors with PTSD. Washington, DC: American Psychiatric Press; 2002.
44. Glassman AH. Cardiovascular effects of antidepressant drugs: updated. J Clin Psychiatry. 1998;59(suppl 15):13-18.